Location History:
- Shreveport, LA (US) (1988)
- Palm Springs, CA (US) (1996)
- Cordova, TN (US) (2005 - 2024)
Company Filing History:
12 out of 261 
4 out of 3,540 
3 out of 9 
Years Active: 1988-2024
Title: Richard Edward Lee - Innovator in Metabolic and Neurologic Disorders
Introduction
Richard Edward Lee, based in Cordova, TN, is a prolific inventor with an impressive portfolio of 21 patents. His work primarily focuses on developing chemical compounds and methods that target various metabolic and neurologic disorders, showcasing his commitment to advancing medical science.
Latest Patents
Among his latest innovations are two significant patents. The first is focused on small molecule modulators of pantothenate kinases aimed at treating metabolic disorders, including type II diabetes and certain neurologic disorders linked to pantothenate kinase-associated neurodegeneration. This patent details chemical compounds that effectively modulate pantothenate kinase (PanK) activity, presenting novel pharmaceutical compositions for treatment.
The second patent describes methods for treating disorders associated with coenzyme A reduction, elevation, sequestration, toxicity, or redistribution (CASTOR) disease. This includes managing conditions like defects in fatty acid oxidation enzymes and other metabolic disorders using small molecule modulators to regulate CoA levels. Both patents serve as essential tools for researchers in the field, providing innovative strategies for treatment.
Career Highlights
Richard Edward Lee has made significant contributions to the medical research community through his work at esteemed institutions such as St. Jude Children's Research Hospital and the United States Department of Health and Human Services. His expertise in metabolic and neurologic disorders has positioned him as a key figure in the development of therapeutic solutions.
Collaborations
Throughout his career, Lee has collaborated with notable professionals in the field, including Ying Zhao and Jiuyu Liu. These partnerships have fostered groundbreaking advancements in research, leading to impactful discoveries and innovations in treatments for complex medical conditions.
Conclusion
Richard Edward Lee's extensive patent portfolio and collaborations highlight his substantial impact on medical innovation. His dedication to addressing critical health challenges through novel compounds and methods continues to inspire advancements in the treatment of metabolic and neurologic disorders. As he moves forward in his career, the contributions of Lee are expected to further influence the landscape of medical research and therapeutic development.